Literature DB >> 30705559

In-hospital low-cost custom made VAC: Effective method for reducing infection in late presenting Open lower limb fractures in overburdened Indian hospitals.

Towseef Ahmad Bhat1, Rouf Ibrahim2, Tariq Ahmad Bhat3, Aejaz Ahmad Bhat4.   

Abstract

BACKGROUND: Open fractures are still associated with troublesome rates of infection. Thorough debridement irrigation and antibiotic cover are of paramount importance irrespective of the fixation method. VAC therapy is a well known method of accelerating the wound healing and decreasing the infection in non healing ulcers. The main drawback of VAC therapy is requirement of a special equipment and high cost. We in our hospital are using low cost custom made VAC therapy for non healing ulcers in lower socio-economic people and have seen extremely good results in wound healing and infection control.
OBJECTIVE: To evaluate the role of pre operative low cost custom made VAC therapy as an adjunctive method of decreasing the rates of infection in late presenting lower limb open fractures.
METHODS: A retrospective study of 26 open femur and tibia fractures for which low cost VAC therapy was used between January 2014 to January 2017.
RESULTS: 2 out of 26 cases (7.4%) ended up with deep infection.
CONCLUSION: Pre operative in-hospital low cost custom made VAC therapy is a useful adjunctive method of reducing infection rates in late presenting open fractures.

Entities:  

Keywords:  Femur; Fracture; Low cost; Tibia; VAC

Year:  2017        PMID: 30705559      PMCID: PMC6349653          DOI: 10.1016/j.jcot.2017.11.010

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  37 in total

1.  Advancing the science and art of orthopaedics. Lessons from history.

Authors:  J A Buckwalter
Journal:  J Bone Joint Surg Am       Date:  2000-12       Impact factor: 5.284

2.  Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial.

Authors:  Chantal M Mouës; Margreet C Vos; Gert-Jan C M van den Bemd; Theo Stijnen; Steven E R Hovius
Journal:  Wound Repair Regen       Date:  2004 Jan-Feb       Impact factor: 3.617

3.  Vacuum-assisted closure: microdeformations of wounds and cell proliferation.

Authors:  Vishal Saxena; Chao-Wei Hwang; Sui Huang; Quentin Eichbaum; Donald Ingber; Dennis P Orgill
Journal:  Plast Reconstr Surg       Date:  2004-10       Impact factor: 4.730

Review 4.  The contaminated high-energy open fracture: a protocol to prevent and treat inflammatory mediator storm-induced soft-tissue compartment syndrome (IMSICS).

Authors:  Lawrence X Webb; Barnaby Dedmond; Dan Schlatterer; David Laverty
Journal:  J Am Acad Orthop Surg       Date:  2006       Impact factor: 3.020

Review 5.  A review of the management of open fractures of the tibia and femur.

Authors:  P V Giannoudis; C Papakostidis; C Roberts
Journal:  J Bone Joint Surg Br       Date:  2006-03

6.  Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial.

Authors:  David G Armstrong; Lawrence A Lavery
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

7.  Vacuum-assisted wound closure after resection of musculoskeletal tumors.

Authors:  Jacob Bickels; Yehuda Kollender; James C Wittig; Nir Cohen; Isaac Meller; Martin M Malawer
Journal:  Clin Orthop Relat Res       Date:  2005-12       Impact factor: 4.176

8.  Experience with wound VAC and delayed primary closure of contaminated soft tissue injuries in Iraq.

Authors:  Brian E Leininger; Todd E Rasmussen; David L Smith; Donald H Jenkins; Christopher Coppola
Journal:  J Trauma       Date:  2006-11

9.  Vacuum-assisted wound closure (VAC therapy) for the management of patients with high-energy soft tissue injuries.

Authors:  Dolfi Herscovici; Roy W Sanders; Julia M Scaduto; Anthony Infante; Thomas DiPasquale
Journal:  J Orthop Trauma       Date:  2003 Nov-Dec       Impact factor: 2.512

10.  A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds.

Authors:  Mark T Eginton; Kellie R Brown; Gary R Seabrook; Jonathan B Towne; Robert A Cambria
Journal:  Ann Vasc Surg       Date:  2003-10-13       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.